Tolerance: A case of self/not-self discrimination maintained by clonal deletion?

Human Immunology

Volumn 52, Issue 2, 1997, Pages 119-126

  Lafferty, Kevin J ^a   Gazda, Lawrence S ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; IMMUNOREACTIVITY; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL;

ALLERGY AND IMMUNOLOGY; ANIMALS; ANTIGEN PRESENTATION; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED NOD; MODELS, BIOLOGICAL; SELF TOLERANCE; T-LYMPHOCYTES;

EID: 0030903868     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(96)00294-7     Document Type: Article

References (45)

1. Silverstein AM: A History of Immunology. San Diego, Academic Press, Inc., 1989.
2. Owen RD: Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102:400, 1945.
3. Burnet FM, Fenner F: The Production of Antibodies. London, Macmillan, 1949.
4. Burnet FM: A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust J Sci 20:67, 1957.
5. Medawar PB: Introduction: definition of the immunologically competent cell. In Wolstenholme GEW, Knight J (eds): The immunologically competent cell: Its nature and origin, in honour of Sir Macfarlane Burnet O.M., vol Ciba Foundation Study Group No. 16. London, J. & A. Churchill, 1963, p 1-4.
6. Bretscher P, Cohn M: A theory of self-nonself discrimination. Science 169:1042, 1970.
7. Lafferty KJ, Cunningham AJ: A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci 53:27, 1975.
8. Lafferty KJ, Warren HS, Woolnough JA, Talmage DW: Immunological induction of T lymphocytes: role of antigen and the lymphocyte costimulator. Blood Cells 4:395, 1978.
9. Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS: Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol 1:143, 1983.
10. Batchelor JR, Welsh K, Burgos H: Transplantation antigens per se are poor immunogens within a species. Nature 273:54, 1978.
11. Zinkernagel RM, Doherty PC: Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248:701, 1974.
12. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 12:991, 1994.
13. Lafferty KJ, Bootes A, Dart G, Talmage DW: Effect of organ culture on the survival of thyroid allografts in mice. Transplantation 22:138, 1976.
14. McCullagh P: The significance of immune suppression in normal self tolerance. Immunol Rev 149:127, 1996.
15. Signore A, Procaccini E, Toscano AM, Ferretti E, Williams AJK, Beales PE, Cugini P, Pozzilli P: Histological study of pancreatic beta-loss in relation to the insulitis process in the non-obese diabetic mouse. Histochemistry 101:263, 1994.
16. Gazda LS, Charlton B, Lafferty KJ: Diabetes results from a late change in the autoimmune response of NOD mice. (Submitted for publication), 1997.
17. Bach JF: Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516, 1994.
18. Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS: Linear loss of beta cell response to intravenous glucose. Diabetes 33:717, 1984.
19. Dotta F, Eisenbarth GS: Type 1 diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of β cell destruction. Clin Immunol Immunopathol 50:585, 1989.
20. Debussche X, Lormeau B, Boitard C, Toublanc M, Assan R: Course of pancreatic beta cell destruction in prediabetic NOD mice: a histomorphometric evaluation. Diabet Metab 20:282, 1994.
21. Shimada A, Charlton B, Taylor-Edwards C, Fathman CG: Beta cell destruction is a late consequence of the autoimmune process in non-obese diabetic mice. Diabetes 45: 1063, 1996.
22. Harada M, Makino S: Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 27:604, 1984.
23. Charlton B, Bacelj A, Slattery RM, Mandel TE: Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes 38:441, 1989.
24. Boitard C, Yasunami R, Dardenne M, Bach JF: T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 169:1669, 1989.
25. Hutchings PR, Cooke A: The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J Autoimmun 3:175, 1990.
26. Sempe P, Richard MF, Bach JF, Boitard C: Evidence of CD4+ regulatory T cells in the non-obese diabetic male mouse. Diabetologia 37:337, 1994.
27. Shimada A, Rohane P, Fathman CG, Charlton B: Pathogenic and protective roles of CD45RB(low) CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 45:71, 1996.
28. Harada M, Kishimoto Y, Makino S: Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diab Res Clin Pract 8:85, 1990.
29. McInerney MF, Pek SB, Thomas DW: Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes 40:715, 1991.
30. Sadelain MWJ, Qin H-Y, Lauzon J, Singh B: Prevention of type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39:583, 1990.
31. Shehadeh NN, Calcinaro F, Bradley BJ, Bruchlim I, Vardi P, Lafferty KJ: Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 343:706, 1994.
32. Gazda LS, Baxter AG, Lafferty KJ: Regulation of autoimmune diabetes: characteristics of non-islet-antigen specific therapies. Immunol Cell Biol 74:401-407, 1996.
33. Penhale WJ, Farmer A, McKenna RP, Irvine WJ: Spontaneous thyroiditis in thymectomized and irradiated Wistar rats. Clin Exp Immunol 15:225, 1973.
34. Fowell D, Mason D: Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J Exp Med 177:627, 1993.
35. Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 172:603, 1953.
36. Streilein JW: Neonatal tolerance of H-2 alloantigens. Procuring graft acceptance the "old-fashioned" way. Transplantation 52:1, 1991.
37. Gill RG, Coulombe M, Lafferty KJ: Pancreatic islet allograft immunity and tolerance: the two-signal hypothesis revisited. Immunol Rev 149:75-96, 1996.
38. Ridge JP, Fuchs EJ, Matzinger P: Neonatal tolerance revisited: turning on newborn T cells with dendritic cells [see comments]. Science 271:1723, 1996.
39. Sarzotti M, Robbins DS, Hoffman PM: Induction of protective CTL responses in newborn mice by a murine retrovirus [see comments]. Science 271:1726, 1996.
40. Forsthuber T, Yip HC, Lehmann PV: Induction of TH1 and TH2 immunity in neonatal mice [see comments]. Science 271:1728, 1996.
41. Alam SM, Travers PJ, Wung JL, Nasholds W, Redpath S, Jameson SC, Gascoigne NR: T-cell-receptor affinity and thymocyte positive selection [see comments]. Nature 381: 616, 1996.
42. Guerder S, Flavell RA: T-cell activation. Two for T. Curr Biol 5:866, 1995.
43. Reiser H, Stadecker MD: Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 335:1369, 1996.
44. Katz JD, Benoist C, Mathis D: T helper cell subsets in insulin-dependent diabetes. Science 268:1185, 1995.
45. Lafferty KJ, Gill RG: The maintenance of self-tolerance. Immunol Cell Biol 71:209-214, 1993.